Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 599–607

doi: 10.17219/acem/69134

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Comparison of two models of inflammatory bowel disease in rats

Cristina S. Catana1,A,B,D, Cristian Magdas2,A,B,D, Flaviu A. Tabaran3,B,C,D, Elena C. Crăciun4,B,C, Georgiana Deak2,B, Virginia A. Magdaş2,B, Vasile Cozma2,E, Călin M. Gherman2,C, Ioana Berindan-Neagoe5,6,7,E, Dan L. Dumitraşcu8,A,F

1 Department of Medical Biochemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

2 Department of Parasitology and Parasitic Diseases, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania

3 Department of Anatomic Pathology, Necropsy and Forensic Medicine, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania

4 Department of Pharmaceutical Biochemistry and Clinical Laboratory, “Iuliu Haţieganu“ University of Medicine and Pharmacy, Cluj-Napoca, Romania

5 Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Haţieganu“ University of Medicine and Pharmacy, Cluj-Napoca, Romania

6 Medfuture Research Center for Advanced Medicine, Cluj-Napoca, Romania

7 Department of Functional Genomics and Experimental Pathology, The Oncology Institute

8 2nd Medical Department, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania


Background. There is a need for experimental animal models for inflammatory bowel diseases (IBD), but no proposed model has been unanimously accepted.
Objectives. The aim of this study was to develop 2 affordable models of IBD in rats and to compare them.
Material and Methods. We produced IBD in rats using either dextran sodium sulfate (DSS) or 2, 4, 6-trinitrobenzene sulfonic acid (TNBS). The requirements for experimental models were: a predictable clinical course, histopathology and inflammation similar to human ulcerative colitis (UC) and Crohn’s disease (CD). The effect of acute administration of DSS and TNBS on oxidative stress (as measured by the assessment of glutathione peroxidase – GPx) was verified. The activity of whole blood GPx was measured using a commercially available Randox kit (Crumlin, UK).
Results. The administration of DSS increased GPx activity compared to the control and TNBS-treated groups, but not to a statistically significant degree. Histological examination of the colonic mucosa following the administration of DSS showed multifocal erosions with minimal to mild inflammatory infiltrate, mainly by polymorphonuclear cells (PMN), lymphocytes and plasma cells. For TNBS-induced colitis, the histological changes manifested as multifocal areas of ulcerative colitis with mild to severe inflammatory infiltrate. Whole blood GPx values displayed a direct dependence on the chemical agent used. Our results show a correlation between histopathology, proinflammatory state and oxidative stress.
Conclusion. The experimental DSSor TNBS-induced bowel inflammation used in this study corresponds to human IBD and is reproducible with characteristics indicative of acute inflammation in the case of the protocols mentioned.

Key words

animal model, colitis, dextran sodium sulfate, 2, 4, 6-trinitrobenzene sulfonic acid, inflammatory bowel disease

References (26)

  1. Kiesler P, Fuss IJ, Strober W. Experimental models of inflammatory bowel diseases. Cell Mol Gastroenterol Hepatol. 2015;1(2):154–170.
  2. Fiocchi C. Inflammatory bowel disease pathogenesis: Where are we? J Gastroenterol Hepatol. 2015;1:12–18.
  3. Cătană CS, Berindan-Neagoe I, Cozma V, Magdaş C, Tăbăran F, Dumitraşcu DL. Contri-bution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2015;21(19):5823–5830.
  4. McCracken JM, Jiang L, Deshpande KT, O’Neil MF, Pritchard MT. Differential effects of hyaluronan synthase 3 deficiency after acute vs chronic liver injury in mice. Fibrogenesis Tissue Repair. 2016;31(9):4. doi:10.1186/s13069-016-0041-5
  5. Sugimoto MA, Vago JP, Teixeira MM, Sousa LP. Annexin A1 and the resolution of in-flammation: Modulation of neutrophil recruitment, apoptosis, and clearance. J Immunol Res. 2016;2016:8239258. doi:10.1155/2016/8239258
  6. Hao LY, Liu X, Franchi L. Inflammasomes in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2013;29:363–369.
  7. Oh SY, Cho KA, Kang JL, Kim KH, Woo SY. Comparison of experimental mouse models of inflammatory bowel disease. Int J Mol Med. 2014;33(2):333–340.
  8. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–1367.
  9. Jiminez JA, Uwiera TC, Douglas Inglis G, Uwiera RR. Animal models to study acute and chronic intestinal inflammation in mammals. Gut Pathog. 2015;7:29. doi:10.1186/s13099-015-0076-y
  10. Yan Y, Kolachala V, Dalmasso G, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One. 2009;4(6):e6073.
  11. Johansson ME, Gustafsson JK, Sjoberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PloS One. 2010;5(8):e12238. doi:10.1371/journal.pone.0012238
  12. Laroui H, Ingersoll SA, Liu HC, et al. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One. 2012;7(3):e32084.
  13. Chami B, Yeung AW, van Vreden C, King, NJ, Bao, B. The role of CXCR3 in DSS-induced colitis. PloS One. 2014;9(7):e101622. doi:10.1371/journal.pone.0101622
  14. Alex P, Zachos NC, Nguyen T, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 2009;15(3):341–352. doi:10.1002/ibd.20753
  15. Pandurangan AK, Ismail S, Saadatdoust Z, Esa NM. Allicin alleviates dextran sodium sulfate- (DSS-) induced ulcerative colitis in BALB/c mice. Oxid Med Cell Longev. 2015;2015:605208. doi:10.1155/2015/605208
  16. Tham DM, Whitin JC, Cohen HJ. Increased expression of extracellular glutathione perox-idase in mice with dextran sodium sulfate-induced experimental colitis. Pediatr Res. 2002;51(5):641–646.
  17. Randhawa PK, Singh K, Singh N, Jaggy AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 2014;18(4):279–288. doi:10.4196/kjpp.2014.18.4.279
  18. Barnett M, Fraser A. Animal models of colitis: Lessons learned, and their relevance to the clinic. In: O’Connor M, ed. Ulcerative Colitis – Treatments, Special Populations and the Future. Rijeka: InTech; 2011:173–178.
  19. Tăbăran AF. Tehnici în histopatologie. In: Cătoi C, Gal A, Taulescu M. Tehnici de Anatomie Patologică Veterinară. Cluj-Napoca, Romania: Editura AcademicPres; 2014:136–153.
  20. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 2002;122(5):1428–1441.
  21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–169.
  22. Drabkin DL, Austin JH. Spectrophotometric studies: Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem. 1932;98:719–733.
  23. Balmus IM, Ciobica A, Trifan A, Stanciu C. The implications of oxidative stress and an-tioxidant therapies in inflammatory bowel disease: Clinical aspects and animal models. Saudi J Gastroenterol. 2016;22(1):3–17. doi:10.4103/1319-3767.173753
  24. Iliev ID, Funari VA, Taylor KD, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 2012;336:1314–1317.
  25. Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014;156(5):1045–1059.
  26. Sokol H, Conway KL, Zhang M, et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology. 2013;145:591–601.